M. Gontika

发表

Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions—a single-center retrospective observational study

M. Dalakas, M. Anagnostouli, L. Stefanis, 2022, Naunyn-Schmiedeberg's Archives of Pharmacology.

Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data

G. Chrousos, M. Dalakas, M. Anagnostouli, 2021, Neurological Sciences.

HLA Allele Frequencies in Pediatric and Adolescent Multiple Sclerosis Patients

M. Anagnostouli, M. Gontika, 2018, Human Leukocyte Antigen (HLA).

Vertebral hemangiomas in the thoracic spine of multiple sclerosis patients are connected with fewer demyelinating lesions at the same level. Possible impact on pathophysiology and clinical course

M. Anagnostouli, A. Kyrozis, E. Kapaki, 2016, Neurological research.

Human leukocyte antigens-immunogenetics of neuromyelitis optica or Devic′s disease and the impact on the immunopathogenesis, diagnosis and treatment: a critical review

M. Anagnostouli, M. Gontika, 2014 .

Novel SCN1A and GABRA1 Gene Mutations With Diverse Phenotypic Features and the Question on the Existence of a Broader Spectrum of Dravet Syndrome

C. Konialis, A. Papavasiliou, M. Gontika, 2017, Child neurology open.

First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center

M. Dalakas, A. Artemiadis, M. Anagnostouli, 2022, Neurological Sciences.

Moderately and Late Preterm Infants: Short- and Long-Term Outcomes From a Registry-Based Cohort

M. Petra, M. Koutsaki, A. Papavasiliou, 2021, Frontiers in Neurology.

HLA-DRB1 differences in allelic distribution between familial and sporadic multiple sclerosis in a Hellenic cohort

A. Artemiadis, M. Anagnostouli, L. Stefanis, 2019, Postgraduate medicine.

Anti-Myelin Oligodendrocyte Glycoprotein and Human Leukocyte Antigens as Markers in Pediatric and Adolescent Multiple Sclerosis: on Diagnosis, Clinical Phenotypes, and Therapeutic Responses

M. Anagnostouli, M. Gontika, 2018, Multiple sclerosis international.

HLA-DPB1*03 as Risk Allele and HLA-DPB1*04 as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort

A. Artemiadis, M. Anagnostouli, L. Stefanis, 2020, Brain sciences.

Multiple Sclerosis and Subsequent Human Immunodeficiency Virus Infection: A Case with the Rare Comorbidity, Focus on Novel Treatment Issues and Review of the Literature.

M. Anagnostouli, Charalampos Skarlis, P. Toulas, 2017, In vivo.

HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort

G. Chrousos, M. Dalakas, A. Artemiadis, 2020, Multiple sclerosis journal - experimental, translational and clinical.